92 related articles for article (PubMed ID: 1345822)
41. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
Yari K; Rahimi Z; Moradi MT; Rahimi Z
Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
[TBL] [Abstract][Full Text] [Related]
42. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Hill SM; Fuqua SA; Chamness GC; Greene GL; McGuire WL
Cancer Res; 1989 Jan; 49(1):145-8. PubMed ID: 2562795
[TBL] [Abstract][Full Text] [Related]
43. [Genetic polymorphism and susceptibility to cancer].
Larsen CJ
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
[TBL] [Abstract][Full Text] [Related]
44. Polymorphism in mtDNA control region of Mizo-Mongloid Breast Cancer samples as revealed by PCR-RFLP analysis.
Ghatak S; Lallawmzuali D; Mukherjee S; Mawia L; Pautu JL; Kumar NS
Mitochondrial DNA A DNA Mapp Seq Anal; 2016 May; 27(3):2205-8. PubMed ID: 25431825
[TBL] [Abstract][Full Text] [Related]
45. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.
Harada Y; Katagiri T; Ito I; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer; 1994 Oct; 74(8):2281-6. PubMed ID: 7922980
[TBL] [Abstract][Full Text] [Related]
46. L-myc polymorphism in cancer patients, healthy blood donors and elderly, tumor-free individuals in Russia.
Togo AV; Suspitsin EN; Grigoriev MY; Ilyushik ES; Karpova MB; Hanson KP; Imyanitov EN
Int J Cancer; 2000 Mar; 85(6):747-50. PubMed ID: 10709089
[TBL] [Abstract][Full Text] [Related]
47. Detection of sequential genetic alterations relevant for breast cancer development.
Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
[TBL] [Abstract][Full Text] [Related]
48. Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women.
Romanowicz-Makowska H; Bryś M; Forma E; Maciejczyk R; Połać I; Samulak D; Michalska M; Smolarz B
Pol J Pathol; 2012 Jun; 63(2):121-5. PubMed ID: 22864780
[TBL] [Abstract][Full Text] [Related]
49. MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Smith PJ
Br J Cancer; 1996 Dec; 74(12):1975-8. PubMed ID: 8980399
[TBL] [Abstract][Full Text] [Related]
50. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
52. Analysis of L-myc gene polymorphism in patients with renal failure outcome to renal transplant.
Yigit B; Bozkurt N; Yaylim I; Titiz I; Isbir T
Transplant Proc; 2006 Jun; 38(5):1267-9. PubMed ID: 16797278
[TBL] [Abstract][Full Text] [Related]
53. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
54. Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer.
Hashemi M; Danesh H; Bizhani F; Sattarifard H; Hashemi SM; Bahari G
Asian Pac J Cancer Prev; 2018 Apr; 19(4):923-926. PubMed ID: 29693343
[TBL] [Abstract][Full Text] [Related]
55. XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
Romanowicz-Makowska H; Sobczuk A; Smolarz B; Fiks T; Kulig A
Pol J Pathol; 2007; 58(4):245-9. PubMed ID: 18459458
[TBL] [Abstract][Full Text] [Related]
56. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
57. No association of hypoxia inducible factor-1α gene polymorphisms with breast cancer in North-West Indians.
Sharma S; Kapahi R; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR
Asian Pac J Cancer Prev; 2014; 15(22):9973-8. PubMed ID: 25520138
[TBL] [Abstract][Full Text] [Related]
58. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis.
Watson PH; Safneck JR; Le K; Dubik D; Shiu RP
J Natl Cancer Inst; 1993 Jun; 85(11):902-7. PubMed ID: 8492318
[TBL] [Abstract][Full Text] [Related]
59. Association of A vitamin D receptor polymorphism with sporadic breast cancer development.
Curran JE; Vaughan T; Lea RA; Weinstein SR; Morrison NA; Griffiths LR
Int J Cancer; 1999 Dec; 83(6):723-6. PubMed ID: 10597185
[TBL] [Abstract][Full Text] [Related]
60. An integrated restriction fragment length polymorphism--amplified fragment length polymorphism linkage map for cultivated sunflower.
Gedil MA; Wye C; Berry S; Segers B; Peleman J; Jones R; Leon A; Slabaugh MB; Knapp SJ
Genome; 2001 Apr; 44(2):213-21. PubMed ID: 11341731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
